Higher cumulative isotretinoin dosages have been associated with lower rates of acne relapse and isotretinoin retrial.

A fixed-dose, triple-combination CAB topical formulation demonstrated efficacy and safety in both adult and pediatric patients with acne.

A small study published in the Journal of Cosmetic Dermatology suggests that omega-3 fatty acids may offer a promising adjunctive...

Isotretinoin is effective and well tolerated in transgender individuals with acne receiving masculinizing gender-affirming hormonal therapy.

The visibility of a skin disorder is directly linked to stigma including bullying.

Testing by Valisure, an independent pharmaceutical quality assurance company, has shown that benzene—a known human carcinogen—can form at...

Multilevel changes may be needed to reduce the impact of acne-related stigma and barriers to acne treatment in trans patients.

Findings from animal model research show promising results for an acne vaccine that targets a pro-inflammatory variant of hyaluronidase...